Retinal cryopexy stimulates traction retinal detachment formation in the presence of an ocular wound.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 2445327)

Published in Arch Ophthalmol on November 01, 1987

Authors

P A Campochiaro1, H C Gaskin, S A Vinores

Author Affiliations

1: Department of Ophthalmology, University of Virginia School of Medicine, Charlottesville 22908.

Articles by these authors

Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol (1998) 2.33

Desmoplastic supratentorial neuroepithelial tumors of infancy with divergent differentiation potential ("desmoplastic infantile gangliogliomas"). Report on 11 cases of a distinctive embryonal tumor with favorable prognosis. J Neurosurg (1987) 2.07

Immunohistochemical demonstration of neuron-specific enolase in neoplasms of the CNS and other tissues. Arch Pathol Lab Med (1984) 1.92

Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci (1998) 1.68

Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res (1997) 1.58

Immunocytochemical labeling of cells in cortical vitreous from patients with premacular hole lesions. Arch Ophthalmol (1992) 1.44

Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown. J Neurosci Res (1997) 1.29

Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells. J Cell Sci (1994) 1.27

Retinal pigment epithelial cells produce PDGF-like proteins and secrete them into their media. Exp Eye Res (1989) 1.14

Photoreceptor-specific expression of platelet-derived growth factor-B results in traction retinal detachment. Am J Pathol (2000) 1.07

Retinal degeneration in transgenic mice with photoreceptor-specific expression of a dominant-negative fibroblast growth factor receptor. J Neurosci (1996) 1.05

Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br J Ophthalmol (1997) 1.04

Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med. Arch Pathol Lab Med (1995) 1.01

Macular oedema: the role of soluble mediators. Br J Ophthalmol (2000) 0.98

Neuron-specific enolase as an immunohistochemical tool for the diagnosis of Hirschsprung's disease. Am J Surg Pathol (1985) 0.95

Blood-aqueous barrier in pseudoexfoliation syndrome: evaluation by immunohistochemical staining of endogenous albumin. Graefes Arch Clin Exp Ophthalmol (1996) 0.92

Retinoic acid promotes density-dependent growth arrest in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (1991) 0.92

Simultaneous expression of glial fibrillary acidic (GFA) protein and neuron-specific enolase (NSE) by the same reactive or neoplastic astrocytes. Neuropathol Appl Neurobiol (1986) 0.89

Hemangiomalike masses of the retina. Arch Ophthalmol (1988) 0.87

Immunoradiometric and immunohistochemical demonstration of neuron-specific enolase in experimental rat gliomas. Cancer Res (1984) 0.86

Electron-immunocytochemical localization of neuron-specific enolase in cytoplasm and on membranes of primary and metastatic cerebral tumours and on glial filaments of glioma cells. Histopathology (1986) 0.86

Electron microscopic localization of neuron-specific enolase in rat and mouse brain. J Histochem Cytochem (1984) 0.84

Normal liver chromatin contains a firmly bound and larger protein related to the principal cytosolic target polypeptide of a hepatic carcinogen. Proc Natl Acad Sci U S A (1984) 0.84

Immunohistochemical evaluation of the integrity of the blood-aqueous barrier in normal and rubeotic human eyes. Graefes Arch Clin Exp Ophthalmol (1995) 0.82

Pathological upregulation of inner blood-retinal barrier Glut1 glucose transporter expression in diabetes mellitus. Brain Res (1996) 0.82

Adenosine and its agonists cause retinal vasodilation and hemorrhages. Implications for ischemic retinopathies. Arch Ophthalmol (1989) 0.81

Class III beta-tubulin isotype (beta III) in the adrenal medulla: III. Differential expression of neuronal and glial antigens identifies two distinct populations of neuronal and glial-like (sustentacular) cells in the PC12 rat pheochromocytoma cell line maintained in a Gelfoam matrix system. Anat Rec (1998) 0.80

Reduction of ethylnitrosourea-induced neoplastic proliferation in rat trigeminal nerves by nerve growth factor. Cancer Res (1982) 0.80

The effect of nerve growth factor on undifferentiated glioma cells. Cancer Lett (1980) 0.79

Nerve growth factor and neural oncology. J Neurosci Res (1983) 0.79

Nerve growth factor modification of the ethylnitrosourea model for multiple schwannomas. Ann N Y Acad Sci (1986) 0.79

Evolution of morphologic changes after intravitreous injection of gentamicin. Curr Eye Res (1993) 0.79

Effect of nerve growth factor producing cells on anaplastic glioma and pheochromocytoma clones: involvement of other factors. J Neurosci Res (1981) 0.78

The effect of nerve growth factor and antibodies to nerve growth factor on ethylnitrosourea carcinogenesis in mice. J Cancer Res Clin Oncol (1980) 0.78

Class III beta-tubulin isotype (beta III) in the adrenal medulla: II. Localization in primary human pheochromocytomas. Anat Rec (1998) 0.78

Class III beta-tubulin isotype (beta III) in the adrenal medulla: I. Localization in the developing human adrenal medulla. Anat Rec (1998) 0.77

Feasibility of laser-targeted photoocclusion of the choriocapillary layer in rats. Invest Ophthalmol Vis Sci (1997) 0.76

Butyrate-induced increase in neuron-specific enolase and ornithine decarboxylase in anaplastic glioma cells. Brain Res (1982) 0.76

Photocoagulation does not ablate angiogenic markers in rabbit retina. Arch Ophthalmol (1988) 0.76

Characteristics of human medulloblastoma cell line TE-671 under different growth conditions in vitro: a morphological and immunohistochemical study. Neuropathol Appl Neurobiol (1986) 0.76

Increased levels of neuron-specific enolase in PC12 pheochromocytoma cells as a result of nerve growth factor treatment. J Neurochem (1981) 0.75

A developmental study of neuron-specific enolase in rat adrenal medulla. J Neurochem (1982) 0.75

The effect of nerve growth factor and antibodies to nerve growth factor on ethylnitrosourea-induced neoplastic proliferation in rat trigeminal nerves. Vet Pathol (1984) 0.75

Immunochemotherapy against a nerve growth factor producing tumor (S-180) using anti-NGF IgG as a carrier for adriamycin. Bull Cancer (1979) 0.75

Hyalocytes synthesize and secrete inhibitors of retinal pigment epithelial cell proliferation in vitro. Arch Ophthalmol (1996) 0.75

Role of nerve growth factor in ethylnitrosourea-induced neural carcinogenesis. J Neurosci Res (1980) 0.75

Decreased micrococcal nuclease sensitivity of nuclei from nerve growth factor-treated PC12 cells. Biochem Biophys Res Commun (1983) 0.75

EMAP cytokine expression in developing retinas of normal and retinal degeneration (rd) mutant mice. J Neuroimmunol (2001) 0.75

Increased adhesion response of anaplastic glioma cells to nerve growth factor and the presence of specific receptors. J Neurosci Res (1983) 0.75